BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/16/2014 1:19:00 PM | Browse: 1184 | Download: 984
|
Received |
|
2012-10-22 18:48 |
|
Peer-Review Started |
|
2012-10-23 08:51 |
|
To Make the First Decision |
|
2012-10-31 13:46 |
|
Return for Revision |
|
2012-11-03 23:26 |
|
Revised |
|
2012-12-29 00:21 |
|
Second Decision |
|
2013-01-23 17:01 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2013-01-24 08:01 |
|
Articles in Press |
|
|
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2013-03-27 21:08 |
|
Publish the Manuscript Online |
|
2013-04-14 19:05 |
Category |
Oncology |
Manuscript Type |
Editorial |
Article Title |
Sorafenib and entecavir: The dioscuri of treatment for advanced hepatocellular carcinoma?
|
Manuscript Source |
Invited Manuscript |
All Author List |
Salvatore D'Angelo, Mario Secondulfo, Raffaele De Cristofano and Paolo Sorrentino |
Funding Agency and Grant Number |
|
Corresponding Author |
Salvatore D'Angelo, MD, Liver Unit, Clinical and Experimental Hepatology, S.G. Moscati Hospital, Contrada Amoretta, 83100 Avellino, Italy. sadangelo@aosgmoscati.av.it
|
Key Words |
Entecavir; Hepatocellular carcinoma; Hepatitis B virus; Liver function; Sorafenib |
Core Tip |
|
Publish Date |
2013-04-14 19:05 |
Citation |
D’Angelo S, Secondulfo M, De Cristofano R, Sorrentino P. Sorafenib and entecavir: The dioscuri of treatment for advanced hepatocellular carcinoma? World J Gastroenterol 2013; 19(14): 2141-2143 |
URL |
http://www.wjgnet.com/1007-9327/full/v19/i14/2141.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v19.i14.2141 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345